BUCHANG PHARMA(SH:603858) Xin Lang Zheng Quan·2025-09-23 02:38Company Overview - Shandong Buchang Pharmaceutical Co., Ltd. is located in Mudan District, Heze City, Shandong Province, established on May 10, 2001, and listed on November 18, 2016 [1] - The company's main business involves the research, production, and sales of traditional Chinese medicine, with revenue composition as follows: Traditional Chinese medicine 82.34%, chemical drugs 10.08%, medical devices 6.61%, and others 0.97% [1] Financial Performance - For the period from January to June 2025, Buchang Pharmaceutical achieved operating revenue of 5.664 billion yuan, a year-on-year increase of 4.27%, and a net profit attributable to shareholders of 628 million yuan, a year-on-year increase of 171.24% [2] - Since its A-share listing, the company has cumulatively distributed dividends amounting to 7.948 billion yuan, with 1.609 billion yuan distributed over the past three years [2] Stock Market Activity - As of September 23, the stock price of Buchang Pharmaceutical was 18.09 yuan per share, with a market capitalization of 19.077 billion yuan [1] - The stock has seen a year-to-date increase of 14.49%, but has declined by 4.08% over the last five trading days and 6.66% over the last twenty days [1] - The company experienced a net outflow of main funds amounting to 6.267 million yuan on September 23, with significant selling pressure observed [1] Shareholder Information - As of June 30, 2025, the number of shareholders for Buchang Pharmaceutical was 55,200, a decrease of 7.32% from the previous period, while the average circulating shares per person increased by 7.89% to 20,054 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited ranked as the seventh largest, holding 11.8743 million shares, an increase of 4.0148 million shares from the previous period [2]